3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
98
Precursor Cell Lymphoblastic Leukemia-Lymphoma
63
Myelodysplastic Syndromes
53
Recurrence
37
Leukemia, Lymphocytic, Chronic, B-Cell
37
Multiple Myeloma
36
Lymphoma, Non-Hodgkin
36
Lymphoma
36
Lymphoma, B-Cell
30
Hematologic Neoplasms
28
Lymphoma, Follicular
24
Lymphoma, Large B-Cell, Diffuse
23
Lymphoma, Mantle-Cell
22
Leukemia
22
Melanoma
21
Lymphoma, B-Cell, Marginal Zone
20
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Myeloproliferative Disorders
19
Hodgkin Disease
19
Leukemia, Biphenotypic, Acute
18
Burkitt Lymphoma
18
Ovarian Neoplasms
17
Pancreatic Neoplasms
15
Neoplasms
13
Leukemia, Myelomonocytic, Chronic
13
Neoplasm Metastasis
11
Colorectal Neoplasms
11
Anemia, Refractory, with Excess of Blasts
11
Stomach Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Interventions
Dexamethasone
3
Bortezomib
3
Cyclophosphamide
2
Clinical Protocols
2
isatuximab
1
daratumumab
1
Tissue Banks
1
Rifaximin
1
Lenalidomide
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
CLR1404
1
Blood Cell Count
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraproteinemias
×
fludarabine
×
1 year
×
Clear all
No trials found.